Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00280371
Other study ID # 201-069
Secondary ID
Status Completed
Phase Phase 3
First received January 19, 2006
Last updated November 9, 2010
Start date January 2006
Est. completion date May 2007

Study information

Verified date February 2008
Source Dey
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine the safety and efficacy of the investigational drug in comparison with a placebo.


Recruitment information / eligibility

Status Completed
Enrollment 345
Est. completion date May 2007
Est. primary completion date July 2006
Accepts healthy volunteers No
Gender Both
Age group 40 Years and older
Eligibility Inclusion Criteria:

- Medical diagnosis of COPD

- Current or prior history of cigarette smoking

Exclusion Criteria:

- Medical diagnosis of asthma

- Chest X-ray diagnostic of significant disease other than COPD

- Significant condition or disease other than COPD

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Formoterol Fumarate


Locations

Country Name City State
United States Research Site Abingdon Virginia
United States Research Site Asheville North Carolina
United States Research Site Atlanta Georgia
United States Research Site Austin Texas
United States Research Site Buena Park California
United States Research Site Camillus New York
United States Research Site Charlotte North Carolina
United States Research Site Cincinnati Ohio
United States Research Site Cincinnati Ohio
United States Research Site Clearwater Florida
United States Research Site Coeur d'Alene Idaho
United States Research Site Costa Mesa California
United States Research Site Cranston Rhode Island
United States Research Site Dallas Texas
United States Research Site DeLand Florida
United States Research Site Denver Colorado
United States Research Site Elizabeth City North Carolina
United States Research Site Henderson Nevada
United States Research Site Hines Illinois
United States Research Site Houston Texas
United States Research Site Huntington Beach California
United States Research Site Jasper Alabama
United States Research Site Long Beach California
United States Research Site Madison Wisconsin
United States Research Site Medford Oregon
United States Research Site Miami Beach Florida
United States Research Site Milwaukee Wisconsin
United States Research Site Minneapolis Minnesota
United States Research Site N. Dartmouth Massachusetts
United States Research Site Normal Illinois
United States Research Site Oklahoma City Oklahoma
United States Research Site Overland Park Kansas
United States Research Site Phoenix Arizona
United States Research Site Portland Oregon
United States Research Site Raleigh North Carolina
United States Research Site Richmond Virginia
United States Research Site Rochester Minnesota
United States Research Site San Diego California
United States Research Site Shawnee Mission Kansas
United States Research Site South Burlington Vermont
United States Research Site Spartanburg South Carolina
United States Research Site St. Louis Missouri
United States Research Site St. Louis Missouri
United States Research Site Stockton California
United States Research Site Summit New Jersey
United States Research Site Tacoma Washington
United States Research Site Tampa Florida
United States Research Site Topeka Kansas
United States Research Site Upland Pennsylvania
United States Research Site Waco Texas
United States Research Site Walnut Creek California
United States Research Site Wheat Ridge Colorado

Sponsors (1)

Lead Sponsor Collaborator
Dey

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measure of lung function
Secondary Change in lung function, as well as vital signs
Secondary Physical Exam results, adverse event reporting, etc
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06000696 - Healthy at Home Pilot
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04043728 - Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study N/A
Completed NCT04105075 - COPD in Obese Patients
Recruiting NCT05825261 - Exploring Novel Biomarkers for Emphysema Detection
Active, not recruiting NCT04075331 - Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic Trial Phase 2/Phase 3
Terminated NCT03640260 - Respiratory Regulation With Biofeedback in COPD N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
Withdrawn NCT04210050 - Sleep Ventilation for Patients With Advanced Hypercapnic COPD N/A
Terminated NCT03284203 - Feasibility of At-Home Handheld Spirometry N/A
Recruiting NCT06110403 - Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness Phase 1/Phase 2
Active, not recruiting NCT06040424 - Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients Phase 3
Recruiting NCT05865184 - Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Recruiting NCT04868357 - Hypnosis for the Management of Anxiety and Breathlessness During a Pulmonary Rehabilitation Program N/A
Completed NCT01892566 - Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV N/A
Completed NCT04119856 - Outgoing Lung Team - a Cross-sectorial Intervention in Patients With COPD N/A
Completed NCT04485741 - Strados System at Center of Excellence
Completed NCT03626519 - Effects of Menthol on Dyspnoea in COPD Patients N/A
Recruiting NCT04860375 - Multidisciplinary Management of Severe COPD N/A